Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-23-042646

Chief Executive Officer sold 12,000 shares at $28.54 ($342,480)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2023-12-20 Sale 10b5-1 −12,000 $28.54 $342,480 3,725,000 D
Open-market sales · 12,000 sh · avg $28.54 · $342,480
Loading xslF345X05/wk-form4_1703282656.xml…